References
- Butenas, S. and Mullertz, S. (2002) Blood coagulation. Biochemistry (Moscow) 67: 3-12 https://doi.org/10.1023/A:1013985911759
- Korea National Statistical Office. (2000) A study on causes of death for 1999
- Cattaneo, F., Trento, F., Pescador, R., Porta, R. and Furro, L. (2002) Pharmacodynamics of the anticoagulant activity (APTT) of an algal polysaccharide. Thromb. Res. 105: 455-457 https://doi.org/10.1016/S0049-3848(02)00047-6
- Molina, V, Arruzazabala, M. L. and Mas, C. R. (2003) Synergistic effect of D-003 and aspirin on experimental throm-bosis models. Prostag.Leukotr. Ess. 68: 305-310 https://doi.org/10.1016/S0952-3278(03)00020-6
- Katira, R., Chauhan, A. and More, R. S. (2005) Direct thrombin inhibitors: novel antithrombotics on the horizon in the thromboprophylactic management of atrial fibrillation. Postgrad. Med. J. 81: 370-375 https://doi.org/10.1136/pgmj.2004.024521
- Weitz, J. I. and Crowther, M. (2002) Direct thrombin inhibitors. Thromb. Res. 106: 275-284 https://doi.org/10.1016/S0049-3848(02)00093-2
- Gwak, H.-S. and Chun, I. K. (2000) Performulation study of aspalatone, a new antithrombotic agent. J. Appl. Pharmacol. 8: 332-337
- Hsieh, K.-H. (1997) Thrombin interaction with fibrin polymerization sites. Thromb. Res. 86: 301-316 https://doi.org/10.1016/S0049-3848(97)00073-X
- Hellgren, M., Johansson, S., Eriksson, U. G and Wahlander, K. (2005) The oral direct thrombin inhibitor, ximelagatran, an alternative for anticoagulant treatment during the puerperium and lactation. BJOG 112: 579-583 https://doi.org/10.1111/j.1471-0528.2004.00494.x
- Gulseth M. P. (2005) Ximelagatran: an orally active direct thrombin inhibitor. Am. J. Health. Syst. Pharm. 62: 1451-1467 https://doi.org/10.2146/ajhp040534
- Lee, T.-B. (1993) Illustrated flora of Korea. Hwang Moon Sa, Seoul
- Sooo, H.-Y, Kwon, Y-S., Kim, Y-S., Kwon, H.-Y, Kwon, G-S., Kim, G-J., Kwon, C.-S. and Son, K. H. (2004) Screening of thrombin inhibitors from medicinal and wild plants. Kor. J. Pharmacogn. 35: 52-61
- Kwon, C.-S., Kwon, Y-S., Kim, Y-S., Kwon, G-S., Jin, I., Ryu, G-C. and Sooo, H.-Y (2004) Inhibitory activities of edible and medicinal herbs against human thrombin. J Life Sci. 14: 509-513 https://doi.org/10.5352/JLS.2004.14.3.509
- Lee, H.-J., Kim, J.-S., Heo, G-Y, Lee, K,-B., Rhee, I.-K. and Song, K.-S. (1999) Inhibitory activities ofbasidiomycetes on prolyl endopeptidase, acetylcholine esterase and coagulation. J. Korean Soc. Agri. Chem. Biotechnol. 42: 336-343
- Hahn,B.-S., Wu, S. and Kim, Y-S. (1999) Evaluation of anticoaguant and fibrinolytic activities from crude extracts. Kor. J. Pharmacogn. 30: 409-412
- Soho, H.-Y, Kwon, C.-S., Son, K.-H., Kwon, G-S., Kwon, Y-S., Ryu, H.-Y. and KUlIl, E.-J. (2005) Antithrombosis and antioxidant activity ofmethanol extract from different brands of rice. J. Kor. Soc. Food Sci. Nutr. 34: 593-598 https://doi.org/10.3746/jkfn.2005.34.5.593
- Bao, J., Cai, Y, Sun, M., Wang, G and Corke, H. (2005) Anthocyanins, flavonols, and free radical scavenging activity of Chinese bayberry (Myrica rubra) extracts and their color properties and stability. J. Agric. Food Chem. 53: 2327-2332 https://doi.org/10.1021/jf048312z
- Kuo, P. L., Hsu, Y. L., Lin, T. C., Lin, L. T. and Lin, C. C. (2004) Induction of apoptosis in human breast adenocarcinoma MCF-7 cells by prodelphinidin B-2 3, 3'-di-O-gallate from Myrica rubra via Fas -mediated pathway. J. Pharm. Pharmacol. 56: 1399-1406 https://doi.org/10.1211/0022357044625